LLY

1,076.96

+0.06%↑

JNJ

207.49

-0.14%↓

ABBV

230.16

+0.01%↑

UNH

331.59

+1.17%↑

AZN

92.89

+0.42%↑

LLY

1,076.96

+0.06%↑

JNJ

207.49

-0.14%↓

ABBV

230.16

+0.01%↑

UNH

331.59

+1.17%↑

AZN

92.89

+0.42%↑

LLY

1,076.96

+0.06%↑

JNJ

207.49

-0.14%↓

ABBV

230.16

+0.01%↑

UNH

331.59

+1.17%↑

AZN

92.89

+0.42%↑

LLY

1,076.96

+0.06%↑

JNJ

207.49

-0.14%↓

ABBV

230.16

+0.01%↑

UNH

331.59

+1.17%↑

AZN

92.89

+0.42%↑

LLY

1,076.96

+0.06%↑

JNJ

207.49

-0.14%↓

ABBV

230.16

+0.01%↑

UNH

331.59

+1.17%↑

AZN

92.89

+0.42%↑

Search

West Pharmaceutical Services Inc

Fermé

SecteurSoins de santé

274.74 -0.61

Résumé

Variation du prix de l'action

24h

Actuel

Min

273.32

Max

275.11

Chiffres clés

By Trading Economics

Revenu

8.2M

140M

Ventes

38M

804M

P/E

Moyenne du Secteur

40.664

78.892

BPA

1.96

Rendement du dividende

0.31

Marge bénéficiaire

17.406

Employés

10,600

EBITDA

19M

217M

Recommandations

By TipRanks

Recommandations

Achat Fort

Prévisions sur 12 Mois

+27.12% upside

Dividendes

By Dow Jones

Rendement du dividende

Moyenne du Secteur

0.31%

2.38%

Date du Prochain Dividende

4 févr. 2026

Date du Prochain Détachement de Dividende

28 janv. 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

9.2M

20B

Ouverture précédente

275.35

Clôture précédente

274.74

Sentiment de l'Actualité

By Acuity

34%

66%

87 / 374 Classement par Healthcare

Score Technique

By Trading Central

Confiance

Strong Bullish Evidence

West Pharmaceutical Services Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

24 déc. 2025, 21:41 UTC

Acquisitions, Fusions, Rachats

Nvidia to Buy Chip-Designer Groq for $20 Billion, CNBC Reports

28 déc. 2025, 23:57 UTC

Résultats

'Avatar: Fire and Ash' Tops Domestic Box Office Again -- Barrons.com

28 déc. 2025, 23:48 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

28 déc. 2025, 23:48 UTC

Market Talk

Global Equities Roundup: Market Talk

28 déc. 2025, 23:48 UTC

Market Talk

Nikkei May Rise on Weaker Yen -- Market Talk

28 déc. 2025, 10:30 UTC

Acquisitions, Fusions, Rachats

There's No Happy Ending for Movie Theaters, No Matter Who Wins Warner -- Heard on the Street -- WSJ

26 déc. 2025, 20:22 UTC

Market Talk

Oil Loses Ground On Russia-Ukraine Peace Efforts -- Market Talk

26 déc. 2025, 20:13 UTC

Market Talk

U.S. Natural Gas Gains on Colder Weather Outlook -- Market Talk

26 déc. 2025, 19:24 UTC

Acquisitions, Fusions, Rachats

Nvidia's Groq Deal Is an Instagram Moment -- With 1 Big Risk -- Barrons.com

26 déc. 2025, 17:45 UTC

Market Talk

U.S. Diesel Down on Lower Crude Prices, Freight-Sector Lull -- Market Talk

26 déc. 2025, 15:52 UTC

Market Talk

Oil Futures Turn Lower After Steady Start -- Market Talk

26 déc. 2025, 14:58 UTC

Market Talk

Silver, Gold Reach New Highs Amid Geopolitical Tension -- Market Talk

26 déc. 2025, 14:41 UTC

Market Talk

U.S. Natural Gas Futures Look to End Week Higher -- Market Talk

26 déc. 2025, 14:28 UTC

Market Talk

Dollar Indexes Flat as Yen Rally Wanes -- Market Talk

26 déc. 2025, 13:47 UTC

Market Talk

Oil Futures Steady in Thin Holiday Trade -- Market Talk

26 déc. 2025, 07:22 UTC

Market Talk

Comex Gold Futures' Strong Bullish Momentum in Play, Chart Shows -- Market Talk

26 déc. 2025, 05:03 UTC

Market Talk

Malaysian Ringgit Likely to Face Pressure From Dollar Strength in 1Q -- Market Talk

26 déc. 2025, 03:38 UTC

Market Talk

Global Equities Roundup: Market Talk

26 déc. 2025, 03:38 UTC

Market Talk

Korean Won Strengthens, Supported by Verbal Interventions -- Market Talk

26 déc. 2025, 02:44 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

26 déc. 2025, 02:44 UTC

Market Talk

Singapore Dollar Weakens Slightly on Likely Position Adjustments -- Market Talk

26 déc. 2025, 01:39 UTC

Market Talk

China's Central Bank Signals Possibility of Easing Policy in Coming Months -- Market Talk

26 déc. 2025, 01:14 UTC

Market Talk

Oil Edges Higher Amid Geopolitical Tensions -- Market Talk

26 déc. 2025, 00:34 UTC

Market Talk

Yen Mostly Weakens Amid Risk-on Sentiment -- Market Talk

26 déc. 2025, 00:15 UTC

Market Talk

Nikkei Gains 0.6%, Led by Tech, Videogame Stocks -- Market Talk

25 déc. 2025, 23:42 UTC

Market Talk

Nikkei May Trade in Range; Yen in Focus -- Market Talk

25 déc. 2025, 23:40 UTC

Market Talk

Gold Edges Higher Amid Geopolitical Risks -- Market Talk

25 déc. 2025, 00:20 UTC

Acquisitions, Fusions, Rachats

Nike Climb Boosts Dow, S&P 500 -- 2nd Update

24 déc. 2025, 22:22 UTC

Acquisitions, Fusions, Rachats

Nvidia, Groq Strike AI Tech Licensing Deal -- Barrons.com

24 déc. 2025, 21:26 UTC

Acquisitions, Fusions, Rachats

Nvidia to Buy Chip-Designer Groq for $20B, CNBC Reports

Comparaison

Variation de prix

West Pharmaceutical Services Inc prévision

Objectif de Prix

By TipRanks

27.12% hausse

Prévisions sur 12 Mois

Moyen 348.7 USD  27.12%

Haut 375 USD

Bas 285 USD

Basé sur 12 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat Fort

12 ratings

10

Achat

2

Maintien

0

Vente

Score Technique

By Trading Central

213.26 / 219.27Support & Résistance

Court Terme

Strong Bullish Evidence

Moyen Terme

Bearish Evidence

Long Terme

Bearish Evidence

Sentiment

By Acuity

87 / 374Classement par Soins de santé

Sentiment de l'Actualité

Indications Haussières

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Moyen

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos West Pharmaceutical Services Inc

West Pharmaceutical Services, Inc. is a global manufacturer in the design and production of technologically advanced, integrated containment and delivery systems for injectable drugs and healthcare products. Its products include various primary packaging, containment solutions, reconstitution, and transfer systems, and drug delivery systems, as well as contract manufacturing, analytical lab services, and integrated solutions. The Company’s segments include Proprietary Products and Contract-Manufactured Products. Proprietary Products reportable segment offers proprietary packaging, containment, and drug delivery products, along with analytical lab services and other integrated services. Contract-Manufactured Products segment manufactures customer-owned components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.
help-icon Live chat